Toronto, Canada

Yuriy Baglaenko

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: University Health Network. Active years: 2019-2020.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Yuriy Baglaenko

Introduction

Yuriy Baglaenko is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medical research, particularly in the area of neurological health. With a total of 2 patents, his work focuses on enhancing the treatment of diseases affecting the brain.

Latest Patents

Yuriy's latest patents include innovative methods, compounds, and compositions for modulating blood-brain barrier integrity and promoting re-myelination. These patents disclose methods and compositions aimed at increasing and decreasing the permeability of the blood-brain barrier. This is crucial for treating various diseases and conditions, as well as facilitating the delivery of therapeutic agents to the brain. The compositions he has developed include RGMa, soluble RGMa, functional fragments and variants thereof, RGMc, soluble RGMc, and Neogenin peptides, including 4Ig.

Career Highlights

Yuriy Baglaenko is affiliated with the University Health Network, where he continues to advance his research and innovations. His work is pivotal in the ongoing efforts to improve neurological health and treatment options.

Collaborations

Yuriy collaborates with esteemed colleagues such as Philippe Patrick Monnier and Nardos G Tassew, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yuriy Baglaenko's contributions to medical research and his innovative patents highlight his commitment to improving brain health. His work continues to pave the way for advancements in the treatment of neurological conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…